Grimes & Company Inc. Has $12.74 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Grimes & Company Inc. grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,756 shares of the healthcare conglomerate’s stock after acquiring an additional 845 shares during the period. Grimes & Company Inc.’s holdings in UnitedHealth Group were worth $12,742,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Richelieu Gestion SA bought a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $26,000. CGC Financial Services LLC increased its holdings in shares of UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares during the period. True Wealth Design LLC bought a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $31,000. LFA Lugano Financial Advisors SA increased its holdings in shares of UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after purchasing an additional 40 shares during the period. Finally, Transcendent Capital Group LLC bought a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $40,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

UNH stock opened at $509.26 on Friday. The firm has a market cap of $468.72 billion, a price-to-earnings ratio of 31.13, a PEG ratio of 1.48 and a beta of 0.58. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The company’s fifty day simple moving average is $498.34 and its 200 day simple moving average is $501.96.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.26 earnings per share. On average, analysts expect that UnitedHealth Group Incorporated will post 27.55 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were paid a $2.10 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 annualized dividend and a yield of 1.65%. The ex-dividend date of this dividend was Monday, June 17th. UnitedHealth Group’s payout ratio is 51.34%.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on UNH shares. Bank of America reissued a “buy” rating and issued a $675.00 price objective on shares of UnitedHealth Group in a research note on Thursday, March 7th. Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research note on Friday, April 19th. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Friday. Finally, JPMorgan Chase & Co. boosted their target price on shares of UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research note on Thursday, May 30th. Three research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.